Sponsored by: InCrowd

Diane Hayes, Ph.D., President and Co-Founder, InCrowd, Inc.

January 25, 2018

Every year, InCrowd surveys physicians across a wide range of specialties to better understand their perspective on healthcare policies and trends, and learn what they think will happen in the year ahead. Join us as we take a look at physician predictions and insights for 20 … Read More »

Sponsored by: Lifelines Neurodiagnostic Systems, Inc.

Simon J. Griffin, BSc Hons, CEO, Lifelines Neurodiagnostic System, Inc.
Pia Mikkelsen Lynch, M.D., President and Managing Director, PML Consulting, Inc.

December 14, 2017

Drug development costs for Central Nervous System (CNS) trials are more complex and costly for pharmaceutical companies and often take longer to develop than other medicines. Failed studies often occur later in development when costs are the highest. For compound efficacy an … Read More »

Sponsored by: Acurian

Dan Brunwasser, Associate Marketing Director, Acurian

December 12, 2017

Ever wonder why 80% of clinical trials are delayed? The top reason is unfulfilled enrollment, and there are specific reasons why this happens with so many trials This webinar will reveal 5 patient enrollment errors that stall enrollment timelines in trial after trial. More i … Read More »

Sponsored by: DocuSign

Jennifer Royer, Director, Regulated Industry Marketing, DocuSign
Jenny Lester, MPH, CCRP, Research Manager for the Women’s Cancer Program, Cedars-Sinai Medical Center
Therica Miller MBA, CCRP, Associate Director, Samuel Oschin Comprehensive Cancer Institute, Cedars Sinai Medical Center

November 15, 2017

One in three people will be diagnosed with cancer in their lifetime, but according to the NIH, only 3-5% of adult cancer patients participate in clinical trials. Advancing therapies in oncology and other disease areas is at the forefront of academic and commercial R&D. B … Read More »

Sponsored by: Manatt Health

Sandy W. Robinson, Managing Director, Manatt Health


Helen Pfister, Partner, Manatt Health
Sandy Robinson, Managing Director, Manatt Health
Annemarie Wouters, Senior Advisor, Manatt Health
Adam Finkelstein, Counsel, Manatt Health

November 14, 2017

New Manatt Health Webinar Reveals the Megatrends Reinventing the Ways Your Patient, Provider and Payer Customers Think—and How You Should Respond to Succeed. Click to Register Free. From the continued evolution of new payment models to the explosion of mHealth to the creatio … Read More »

Sponsored by: Acurian

Professor Alan Palmer FRSB PhD, MSc, BSc, Board Director of The Brain Tumour Charity
Kathryn M. Martin, M.A., Manager of Patient Recruitment Strategy, Acurian

May 2, 2017

There is scientific knowledge. And there is public perception. And often, the two collide. Nowhere is this reality more explicit than with the current state of Alzheimer’s disease research. Without a definitive cause or diagnosis – and no cure in sight – many adults see no r … Read More »

Sponsored by: Cardinal Health Regulatory Sciences

Diane Beatty, PhD, Managing Director, Regulatory Affairs and Product Development, Cardinal Health Regulatory Sciences
Todd Phillips, PharmD, RAC, Principal Scientist, Regulatory Affairs and Product Development, Cardinal Health Regulatory Sciences

April 12, 2017

FDA is committed to advancing the development of therapies that treat serious conditions and rare diseases. As part of this commitment, FDA offers expedited programs for biopharmaceutical companies to reduce development and review timelines for new drugs and biologics that a … Read More »

Sponsored by: Acurian

Roger Smith, Senior Vice President & General Manager, Acurian

April 11, 2017

After decades of delayed trial timelines, slow site setup and poor patient enrollment remain the top barriers to completing clinical studies on time and on budget. However, a new trial model has surfaced that flattens these obstacles and provides sponsors with the enrollment … Read More »

Sponsored by: Cardinal Health Specialty Solutions

Cathy Patten, Director of Clinical Operations, Cardinal Health Sonexus™ Access & Patient Support
Chadi Nabhan, MD, MBA, FACP, Chief Medical Officer, Cardinal Health Specialty Solutions

March 8, 2017

While economic reforms drive sweeping changes in healthcare, the reimbursement and access landscape for specialty drugs continues to grow more challenging. For patients facing serious illnesses and their healthcare providers, navigating the prior-authorization requirements a … Read More »

Sponsored by: DocuSign

Andrea Bradbury, Co-Founder and Chief Quality Officer, Suvoda
Jennifer Royer, Director, Life Sciences Product Marketing, DocuSign

January 25, 2017

Nearly 50% of business leaders fear they will become obsolete over the next several years, and nearly 80% feel threatened by digital startups. Why? New technologies and digital strategies are challenging existing business models and forcing companies of all sizes to reimagin … Read More »

Sponsored by: RAPP

Maryann Kuzel, SVP, Head of Healthcare Strategy, North America

November 30, 2016

There’s a population tsunami approaching: the coming of age of the Gen X and Millennial generations. And it’s fueling the rise of the new Patient Economy. These generations account for about 50% of the U.S. population, and they are a powerful force for change. In the new Pat … Read More »

Sponsored by: Cello Health

Jim Hall, President, Cello Health, BioConsulting

November 17, 2016

To be successful in developing a pharmaceutical asset you have to identify the need and define the commercial value early on in the development process, as well as revisiting and refining the value as you progress through the various phases of development. This means underst … Read More »

Sponsored by: Manatt Health

Melinda Dutton, Partner, Manatt Health
Jon Glaudemans, Managing Director, Manatt Health
Sandy Robinson, Managing Director, Manatt Health

November 16, 2016

Exciting advances in science have led to developing treatment breakthroughs—such as gene scripting therapies—that could represent the first potential cures for rare diseases and other life-threatening conditions.  Gene therapies offer dramatic promise—but also come with high … Read More »

Sponsored by: InCrowd

Caleb Costa, Moderator, Senior Vice President, Client Success
Charles Lonardo, Director of Training and Compliance
Remy Morrison, Account Director for Client Services and Syndicated Data

October 19, 2016

The tracking study is a cornerstone of good market research. But what happens when you are faced with budget cuts, unforeseen market changes, or urgent data needs? Powerful, real-time tracking technologies can help fill these gaps and complement your traditional ATU when you … Read More »

Sponsored by: Worldwide Clinical Trials

Dr. Michael Murphy, M.D., Ph.D., Chief Medical and Scientific Officer
Karen Hill, VP Global Operations, Cardiovascular
Toni Bransford, Senior Medical Director, Medical & Scientific Affairs
Chris Standley, VP Trial Technologies

September 29, 2016

Cardiovascular outcome studies can be a bit like piloting the Queen Mary – multiple compartments, complex interrelated activities, difficult to launch and bring into port. To commemorate World Heart Day on September 29th, Worldwide Clinical Trial experts will highlight commo … Read More »

Sponsored by: Cardinal Health Specialty Solutions

Kristene Castle, Principal Scientist, Regulatory Affairs and Product Development, Regulatory Sciences
Kaitlyn Riffel, Scientist III, Regulatory Affairs and Product Development, Regulatory Sciences

June 23, 2016

Standard for Exchange of Nonclinical Data (SEND) is a new formatting requirement for the submission of electronic data to the FDA. This initiative is led by the Clinical Data Interchange Standards Consortium (CDISC) with the intent to integrate clinical Study Data Tabulation … Read More »

Sponsored by: DocuSign®

Michael Hovanyetz, Director, Business Technology Team, Pfizer
Shari Perlstein, Sr. Director, Enterprise Records & Information Management, Pfizer
Ellen Reilly, Vice President, Life Sciences and Healthcare, DocuSign

June 22, 2016

Your business, your patients, and your supply chain are all global and mobile – so it’s no surprise that over 80% of life science executives are investing in a globally integrated supply chain and collaborative business models. Pharmaceutical leaders are embracing fully digi … Read More »

Sponsored by: Prolifiq Software

Jeff Gaus, CEO, Prolifiq Software
Jennifer Muszik, Owner, Jennifer Muszik, LLC

April 12, 2016

Whether you call it an evolution or a revolution, the US Healthcare market is going through considerable change.  Since the HITECH Act in 2009 and the Affordable Care Act in 2010, we have seen significant consolidation of provider organizations and the introduction of many n … Read More »

Sponsored by: DocuSign

Ellen Reilly, VP, Life Sciences & Healthcare, DocuSign
Robert Albert, Collaboration Delivery Lead, AstraZeneca

November 10, 2015

Nearly 90% of pharmaceutical executives agree that digital technologies are crucial to increasing efficiency and improving the customer experience. Investing in digital operations across your enterprise – from procurement contracts to 1572 forms – helps you launch products s … Read More »

Sponsored by: ERT

Stephen Badiali, Sales Engineer, Insights Cloud, ERT

October 15, 2015

Industry buzzwords like Big Data and Risk-based Monitoring are dominating industry forums, and clinical research organizations are exploring how they can leverage data analytics to change the paradigm of their clinical research processes. However, with study teams inundated … Read More »

Sponsored by: Zitter Health Insights

Pamela Morris, Director of Syndicated Research, Zitter Health Insights

September 17, 2015

Claims data highlight a portion of script abandonment, but don’t capture patients who never get to the pharmacy. Zitter Health Insights’ new and innovative research on script abandonment not only captures all types of abandonment, including before patients even get to the ph … Read More »